ETFis Series Trust I - Virtus LifeSci Biotech Clinical Trials ETF Balance Sheet Health
Financial Health criteria checks 0/6
Insufficient data to determine the health of ETFis Series Trust I - Virtus LifeSci Biotech Clinical Trials ETF
Key information
n/a
Debt to equity ratio
n/a
Debt
| Interest coverage ratio | n/a |
| Cash | n/a |
| Equity | n/a |
| Total liabilities | n/a |
| Total assets | n/a |
Recent financial health updates
No updates
Recent updates
No updates
In this section we usually analyse ETFis Series Trust I - Virtus LifeSci Biotech Clinical Trials ETF's finance health to determine how well-positioned it is against times of financial distress, in particular, its ability to manage its cash and debt levels. ETFis Series Trust I - Virtus LifeSci Biotech Clinical Trials ETF has not provided adequate balance sheet data, its financial health cannot be properly assessed as it.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have financial information.
Financial Position Analysis
Short Term Liabilities: Insufficient data to determine if BBC's short term assets cover its short term liabilities.
Long Term Liabilities: Insufficient data to determine if BBC's short term assets cover its long term liabilities.
Debt to Equity History and Analysis
Debt Level: Insufficient data to calculate BBC's net debt to equity ratio to determine if it is satisfactory.
Reducing Debt: Insufficient data to determine if BBC's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: Insufficient data to determine if BBC's debt is well covered by operating cash flow.
Interest Coverage: Insufficient data to determine if BBC's interest payments on its debt are well covered by EBIT.